This BCC report explores the dynamic and changing environment of prescription allergy treatments and analyzes the major issues affecting the market. This market has been under intense scrutiny from all different factions and the major decisions and changes that are occurring will likely shape the market of the future. The report covers antihistamines and combinations, decongestants and combinations, corticosteroids and mast cell stabilizers. The purpose of the report is to assess the market presence, production base, corporate ethos, and recent and future strategic marketing activities of manufacturers involved in this market. The report discusses issues from the pharmaceutical manufacturer standpoint, the insurance industry standpoint and the public standpoint. Recommendations of solutions, medico-legal repercussions, and progress in allergy treatment development are also discussed. Key participants in the market are profiled using up-to-the-minute data and analysis from the very latest manufacturer and supplier interviews. The market analysis offers manufacturer and share information for all major products. Patient populations and market estimates as well as growth rates are presented for 1999, 2000, 2001 and 2006. 118 pages.